Market Cap | 21.61M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
Income | -21.01M | Forward P/E | -0.74 | EPS next Y | - | 50D Avg Chg | 3.00% |
Sales | 32.88M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -32.00% |
Dividend | N/A | Price/Book | 0.62 | EPS next 5Y | 20.00% | 52W High Chg | -78.00% |
Recommedations | - | Quick Ratio | 1.99 | Shares Outstanding | 5.26M | 52W Low Chg | 30.00% |
Insider Own | 9.65% | ROA | -16.02% | Shares Float | 4.77M | Beta | 2.48 |
Inst Own | 14.94% | ROE | -76.23% | Shares Shorted/Prior | 99.16K/69.14K | Price | 0.26 |
Gross Margin | 23.46% | Profit Margin | -63.90% | Avg. Volume | 198,593 | Target Price | - |
Oper. Margin | -20.19% | Earnings Date | Nov 12 | Volume | 126,499 | Change | -7.17% |
XWELL, Inc. provides health and wellness services in airport and off airport marketplaces in the United States and internationally. It operates in four segments: XpresSpa, XpresTest, Naples Wax Center, and Treat. The XpresSpa segment traveler's spa services, including massage, nail, and skin care services, as well as spa and travel products. The XpresTest segment offers diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public but has transitioned to the CDC's bio-surveillance program; and provides marketing support through HyperPointe business to various health and health-related channels. The Napple Wax Center segment offers skincare and cometic products, as well as face and body waxing services. The Treat segment provides access to wellness services for travelers at on-site centers, consisting of self-guided yoga, meditation, and low impact weight exercises programs. The company offers its services through stores, kiosks, and online. The company was formerly known as XpresSpa Group, Inc. and changed its name to XWELL, Inc. in October 2022. XWELL, Inc. is based in New York, New York.
HC Wainwright & Co. | Buy | Nov 17, 23 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
WEINSTEIN ROBERT | Director Director | May 30 | Buy | 0.2470 | 25,000 | 6,175 | 156,485 | 05/31/23 |
WEINSTEIN ROBERT | Director Director | May 26 | Buy | 0.25 | 25,000 | 6,250 | 131,485 | 05/30/23 |
Ernst Ezra | See Remarks See Remarks | Jun 17 | Buy | 0.7935 | 12,602 | 10,000 | 22,602 | 06/21/22 |
Milford Scott R | Chief Executive Offi.. Chief Executive Officer | Apr 11 | Sell | 1.09 | 25,020 | 27,272 | 12,405 | 04/25/22 |
WEINSTEIN ROBERT | Director Director | Apr 20 | Sell | 1.06 | 45,000 | 47,700 | 106,485 | 04/22/22 |
Bernstein Bruce | Director Director | Mar 17 | Buy | 1.23 | 5,000 | 6,150 | 729,198 | 03/21/22 |
Bernstein Bruce | Director Director | Mar 07 | Sell | 0.9952 | 15,000 | 14,928 | 724,198 | 03/09/22 |
Bernstein Bruce | Director Director | Jan 21 | Sell | 1.4618 | 25,000 | 36,545 | 676,698 | 01/24/22 |
WEINSTEIN ROBERT | Director Director | Jan 19 | Sell | 1.5608 | 45,000 | 70,236 | 120,235 | 01/21/22 |